Author:
Huang Yan,Liang Wenhua,Yang Yunpeng,Zhao Liping,Zhao Hongyun,Wu Xuan,Zhao Yuanyuan,Zhang Yang,Zhang Li
Funder
National High Technology Research and Development Program of China
Molecular Classification, Personalized Diagnosis and Therapy of Nasopharyngeal Carcinoma
Sun Yat-Sen University Clinical Medical Research Project 5010
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference47 articles.
1. Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer. 2011;30:114–9.
2. Hutajulu SH, Kurnianda J, Tan IB, Middeldorp JM. Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma. Ther Clin Risk Manag. 2014;10:721–36.
3. Bensouda Y, Kaikani W, Ahbeddou N, Rahhali R, Jabri M, Mrabti H, et al. Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128:79–85.
4. National Cancer Institute [Internet]. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Head and Neck Cancers Version 2.2014 [cited 2014 Oct 9]. Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
5. Chan AT, Grégoire V, Lefebvre JL, Licitra L, Hui EP, Leung SF, et al. Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(7):vii83–5.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献